Clinical Trials
5 trialsNCT03827837 2022-07-01
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT05311566 2022-04-13
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT05151549 2021-12-09
A Study of Carilizumab Combined With Concurrent Chemoradiotherapy
Hunan Cancer Hospital
Phase 2 Unknown
NCT04974944 2021-10-01
First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT04974827 2021-08-10
A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer
Hunan Cancer Hospital
Phase 2 Unknown